Seasonal differences of peak expiratory flow rate variability and mediators of allergic inflammation in non-atopic adolescents

Pediatric Allergy and Immunology

Volumn 12, Issue 5, 2001, Pages 238-246

  Ferdousi, Hosne Ara ^a   Munir, A K M ^a   Zetterström, Olle ^b   Dreborg, Sten K G ^a,b  

^a LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

^b University Hospital ^*

Author keywords

Eosinophil cationic protein; Eosinophil protein X; Myeloperoxidase; Peak expiratory flow rate; Peak expiratory flow rate variability; Phadiatoffii; Specific IgE; U eosinophil protein X:creatinine ratio

Indexed keywords

CREATININE; EOSINOPHIL CATIONIC PROTEIN; EOSINOPHIL PROTEIN X; IMMUNOGLOBULIN E; MYELOPEROXIDASE;

ADOLESCENT; ALLERGY; ARTICLE; CORRELATION FUNCTION; EOSINOPHILIA; FEMALE; HUMAN; MALE; MEDIATOR RELEASE; NEUTROPHIL; NORMAL HUMAN; PEAK EXPIRATORY FLOW; POLLEN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN URINE LEVEL; RADIOIMMUNOASSAY; SEASONAL VARIATION;

ADOLESCENT; ADULT; AGE FACTORS; BLOOD PROTEINS; CHILD; CREATININE; EOSINOPHIL GRANULE PROTEINS; EPITOPES; FEMALE; HUMANS; HYPERSENSITIVITY, IMMEDIATE; IMMUNIZATION; IMMUNOGLOBULIN E; INFLAMMATION MEDIATORS; MALE; PEAK EXPIRATORY FLOW RATE; PEROXIDASE; POLLEN; REFERENCE VALUES; RIBONUCLEASES; SEASONS; STATISTICS; SWEDEN;

EID: 0034752082     PISSN: 09056157     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-3038.2001.00024.x     Document Type: Article

References (40)

1. The distribution of peak expiratory flow variability in a population sample
2. Peak flow records in surveys: Reproducibility of observer's reports
3. Variability of peak flow in wheezy children
4. Interpretation of the variability of peak flow rates in chronic bronchitis
5. Diurnal variation in airflow obstruction in chronic bronchitis
6. Bronchial responsiveness to histamine: Relationship to diurnal variation of peak flow rate, improvement after bronchodilator, and airway calibre
7. Monitoring of peak expiratory flow rates in subjects with mild airway hyperexcitability
8. The normal range of diurnal changes in peak expiratory flow rates: Relationship to symptoms and respiratory disease
9. Asthma and inflammation
10. Eosinophilic inflammation in asthma
11. Asthma in children less than 5 years of age: Eosinophil proteins ECP and EPX in relation to atopy and symptoms
12. Total blood eosinophils, serum eosinophil cationic protein and eosinophil protein X in childhood asthma: Relation to disease status and therapy
13. Eosinophil cationic protein in peripheral blood of pediatric patients with allergic diseases
14. Eosinophils, serum eosinophil cationic protein (ECP), serum and urine eosinophil-derived neurotoxin (EDN) in children with moderate asthma, compared with healthy controls
15. Clinical value of monitoring eosinophil activation in asthma
16. Urinary eosinophilic protein X in children with atopic asthma: A useful marker of anti-inflammatory treatment
17. Eosinophil cationic protein, myeloperoxidase and tryptase in children with asthma and atopic dermatitis
18. Eosinophilic cationic protein and tidal flow volume loops in children 0-2 years of age
19. Urinary eosinophil protein X in relation to disease activity in childhood asthma
20. Soluble markers of allergic inflammation
21. Granulocyte proteins in serum in childhood asthma: Relation to spirometry and therapy
22. Markers of airway inflammation in preschool wheezers
23. The differential release of eosinophil granule proteins. Studies on patients with acute bacterial and viral infections
24. Asthma, bronchial hyperreactivity and mediator release in children with birch pollinosis
25. Degranulation of eosinophils from pollen-atopic patients with asthma is increased during pollen season
26. PAT - The Preventive Allergy Treatment study design and preliminary results
27. Radioimmunoassay of Human eosinophil cationic protein (ECP) by an improved method. Establishment of normal levels in serum and turnover in vivo
28. Serum myeloperoxidase and lactoferrin in neutropenia
29. Changes in serum ECP levels after storage at room temperature
30. Injury to murine airway epithelial cells by pollen enzymes
31. Triggering of the vascular permeability reaction by activation of the Hageman factor-kallikrein system by house dust mite proteinase
32. Development of IgG subclass antibodies to ovalbumin, birch and cat during the first eight years of life in atopic and non-atopic children
33. Serum inflammatory markers and effects of age and tobacco smoke exposure in young non-asthmatic children
34. Markers of airway inflammation in preschool wheezers
35. Molecular cloning and characterization of chromosomal gene human eosinophil peroxidase
36. Chromosomal gene structure of human myeloperoxidase and regulation of its expression by granulocyte colonystimulating factor
37. Localization of the human estrogen-responsive finger protein (EEP) gene (ZNF 147) within a YAC contig containing the myeloperoxidase (MPO) gene
38. The eosinophil peroxidase gene forms a cluster with the genes for myeloperoxidase and lactoperoxidase on human chromosome 17
39. The normal range of diurnal changes in peak expiratory flow rates
40. Comparison of normal and asthmatic circadian rhythms in peak expiratory flow rate